Old Web
English
Sign In
Acemap
>
authorDetail
>
Weihong Zhao
Weihong Zhao
Chinese PLA General Hospital
Cancer research
Breast cancer
Medicine
Paclitaxel
Docetaxel
4
Papers
19
Citations
0.00
KQI
Citation Trend
Filter By
Interval:
1900~2024
1900
2024
Author
Papers (4)
Sort By
Default
Most Recent
Most Early
Most Citation
No data
Journal
Conference
Others
Anlotinib in combination with TQB2450 in patients with recurrent ovarian cancer (ACTION): A multicenter, single-arm, open-label, phase Ib trial.
2021
Journal of Clinical Oncology
Chunyan Lan
Jing Zhao
Fan Yang
Rong Li
Yu Huang
Wang Jing
Weihong Zhao
Li Zhang
Chang Liu
Xuehan Bi
Haihong Jin
Jin Meng
Xin Huang
Show All
Source
Cite
Save
Citations (0)
Platinum-based chemotherapy in advanced triple-negative breast cancer: a multicenter real-world study in China.
2020
International Journal of Cancer
Yimeng Chen
Yin Guan
Jiayu Wang
Fei Ma
Yang Luo
Shanshan Chen
Pin Zhang
Qing Li
Ruigang Cai
Qiao Li
Hongnan Mo
Bo Lan
Xuelian Chen
Weihong Zhao
Binghe Xu
Ying Fan
Show All
Source
Cite
Save
Citations (3)
Nab-paclitaxel-based regimens with docetaxel-based regimens as neoadjuvant treatment for early breast cancer.
2020
Investigational New Drugs
Yimeng Chen
Baoshi Bao
Yao Lv
Decong Sun
Li Zhang
Jiandong Wang
Weihong Zhao
Show All
Source
Cite
Save
Citations (2)
Overexpression of centrosomal protein Nlp confers breast carcinoma resistance to paclitaxel.
2012
Cancer Biology & Therapy
Weihong Zhao
Yongmei Song
Binghe Xu
Qimin Zhan
Show All
Source
Cite
Save
Citations (14)
1